DOVATO
Identification of Dovato
| No description |
Google image searchProduct monograph
Active ingredients
dolutegravir (dolutegravir sodium), 50 MG
lamivudine, 300 MG
DIN: 02491753
Dosage form(s): TABLET
Route(s) of administration: ORAL
Schedule: Prescription
Company: VIIV HEALTHCARE ULC
Date: 09-SEP-2019
ATC:
- J05 — ANTIVIRALS FOR SYSTEMIC USE (ATC, ATC/DDD, )
- J05A — DIRECT ACTING ANTIVIRALS (ATC, ATC/DDD)
- J05AR — Antivirals for treatment of HIV infections, combinations (ATC, ATC/DDD)
- J05AR25 — LAMIVUDINE AND DOLUTEGRAVIR (ATC/DDD)
Reference brand drug: Dovato
